Cell therapy for cystic fibrosis

Journal of Tissue Engineering and Regenerative Medicine

Volumn 9, Issue 3, 2015, Pages 210-223

  Murphy, Sean V ^a   Atala, Anthony ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Animal models; Bioengineering; Cell therapy; Cystic fibrosis; Differentiation; Disease modelling; Inflammation; Stem cells

Indexed keywords

CYTOLOGY; DISEASE CONTROL; DISEASES; PATIENT TREATMENT; TISSUE REGENERATION;

ANIMAL MODEL; BIOENGINEERING; CELL THERAPY; CYSTIC FIBROSIS; DIFFERENTIATION; DISEASE MODELS; DISEASE SYMPTOMS; REGENERATIVE MEDICINE; REPAIR MECHANISM; STEM-CELL;

STEM CELLS;

BIOENGINEERING; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CYSTIC FIBROSIS; DISEASE COURSE; EMBRYONIC STEM CELL; ENDOGENOUS LUNG STEM CELL; ENGRAFTMENT; GENE TARGETING; GESTATIONAL STEM CELL; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIFE EXPECTANCY; LUNG BIOENGINEERING; LUNG INFECTION; MESENCHYMAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY EPITHELIUM; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; ANIMAL; BIOLOGICAL THERAPY; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; REGENERATIVE MEDICINE;

ANIMALS; CELL DIFFERENTIATION; CELL- AND TISSUE-BASED THERAPY; CYSTIC FIBROSIS; HUMANS; REGENERATIVE MEDICINE; STEM CELLS;

EID: 84925610963     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1746     Document Type: Review

References (130)

1. Assady S, Maor G, Amit M, et al. 2001; Insulin production by human embryonic stem cells. Diabetes 50(8): 1691-1697.
2. Ballas CB, Zielske SP, Gerson SL. 2002; Adult bone marrow stem cells for cell and gene therapies: implications for greater use. J Cell Biochem Suppl 38(1): 20-28.
3. Berger MJ, Adams SD, Tigges BM, et al. 2006; Differentiation of umbilical cord blood-derived multilineage progenitor cells into respiratory epithelial cells. Cytotherapy 8(5): 480-487.
4. Bergsson G, Reeves EP, McNally P, et al. 2009; LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline. J Immunol 183(1): 543-551.
5. Bobadilla JL, Macek M Jr, Fine JP, et al. 2002; Cystic fibrosis: a worldwide analysis of CFTR mutations - correlation with incidence data and application to screening. Hum Mutation 19(6): 575-606.
6. Bonvillain RW, Danchuk S, Sullivan DE, et al. 2012; A non-human primate model of lung regeneration: detergent-mediated decellularization and initial in vitro recellularization with mesenchymal stem cells. Tissue Eng Part A 18(23-24): 2437-2452.
7. Borowitz D 2005; Update on the evaluation of pancreatic exocrine status in cystic fibrosis. Curr Opin Pulm Med 11(6): 524-527.
8. Bosch P, Musgrave DS, Lee JY, et al. 2000; Osteoprogenitor cells within skeletal muscle. J Orthop Res 18(6): 933-944.
9. Bruscia E, Sangiuolo F, Sinibaldi P, et al. 2002; Isolation of CF cell lines corrected at ΔF508-CFTR locus by SFHR-mediated targeting. Gene Ther 9(11): 683-685.
10. Bruscia EM, Price JE, Cheng EC, et al. 2006a; Assessment of cystic fibrosis transmembrane conductance regulator (CFTR) activity in CFTR-null mice after bone marrow transplantation. Proc Natl Acad Sci USA 103(8): 2965-2970.
11. -/- mice. Am J Resp Cell Mol Biol 40(3): 295-304.
12. Bruscia EM, Ziegler EC, Price JE, et al. 2006b; Engraftment of donor-derived epithelial cells in multiple organs following bone marrow transplantation into newborn mice. Stem Cells 24(10): 2299-2308.
13. Busch R 1990; On the history of cystic fibrosis. Acta Univ Carolin Med 36(1-4): 13-15.
14. Caplan AI, Dennis JE. 2006; Mesenchymal stem cells as trophic mediators. J Cell Biochem 98(5): 1076-1084.
15. Cargnoni A, Gibelli L, Tosini A, et al. 2009; Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant 18(4): 405-422.
16. Carraro G, Perin L, Sedrakyan S, et al. 2008; Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells 26(11): 2902-2911.
17. Cheng K, Ashby D, Smyth RL. 2011; Oral steroids for long-term use in cystic fibrosis. Cochrane Database Syst Rev 10(CD000407): DOI: 10.1002/14651858.CD000407.pub2.
18. Cheng SH, Gregory RJ, Marshall J, et al. 1990; Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63(4): 827-834.
19. Chu CS, Trapnell BC, Curristin SM, et al. 1992; Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis. J Clin Invest 90(3): 785-790.
20. Cilento BG, Freeman MR, Schneck FX, et al. 1994; Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro. J Urol 152(2, pt 2): 665-670.
21. Cohen TS, Prince A. 2012; Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med 18(4): 509-519.
22. Cole BB, Smith RW, Jenkins KM, et al. 2010; Tracheal basal cells: a facultative progenitor cell pool. Am J Pathol 177(1): 362-376.
23. Conese M, Ascenzioni F, Boyd AC, et al. 2011; Gene and cell therapy for cystic fibrosis: from bench to bedside. J Cystic Fibros 10(2): 114-128.
24. Cortiella J, Niles J, Cantu A, et al. 2010; Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. Tissue Eng Part A 16(8): 2565-2580.
25. Crisan M, Casteilla L, Lehr L, et al. 2008; A reservoir of brown adipocyte progenitors in human skeletal muscle. Stem Cells 26(9): 2425-2433.
26. Daly AB, Wallis JM, Borg ZD, et al. 2012; Initial binding and recellularization of decellularized mouse lung scaffolds with bone marrow-derived mesenchymal stromal cells. Tissue Eng Part A 18(1-2): 1-16.
27. De Bari C, Dell'Accio F, Tylzanowski P, et al. 2001; Multipotent mesenchymal stem cells from adult human synovial membrane. Arthr Rheumat 44(8): 1928-1942.
28. De Coppi P, Bartsch G Jr, Siddiqui MM, et al. 2007; Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25(1): 100-106.
29. Deleu S, Gonzalez-Merino E, Gaspard N, et al. 2009; Human cystic fibrosis embryonic stem cell lines derived on placental mesenchymal stromal cells. Reprod Biomed Online 18(5): 704-716.
30. Di A, Brown ME, Deriy LV, et al. 2006; CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat Cell Biol 8(9): 933-944.
31. Dodge JA. 1995; Male fertility in cystic fibrosis. Lancet 346(8975): 587-588.
32. Dominici M, Le Blanc K, Mueller I, et al. 2006; Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4): 315-317.
33. Donaldson SH, Bennett WD, Zeman KL, et al. 2006; Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 354(3): 241-250.
34. Driskell RA, Engelhardt JF. 2003; Current status of gene therapy for inherited lung diseases. Annu Rev Physiol 65(1): 585-612.
35. Engelhardt JF, Schlossberg H, Yankaskas JR, et al. 1995; Progenitor cells of the adult human airway involved in submucosal gland development. Development 121(7): 2031-2046.
36. Friedenstein AJ, Deriglasova UF, Kulagina NN, et al. 1974; Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2(2): 83-92.
37. George PM, Banya W, Pareek N, et al. 2011; Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007. Br Med J 342(1): d1008.
38. Giangreco A, Reynolds SD, Stripp BR. 2002; Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol 161(1): 173-182.
39. Gotts JE, Matthay MA. 2011; Mesenchymal stem cells and acute lung injury. Crit Care Clin 27(3): 719-733.
40. Grubb BR, Boucher RC. 1999; Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev 79(1): 193-214.
41. Guilbault C, Saeed Z, Downey GP, et al. 2007; Cystic fibrosis mouse models. Am J Resp Cell Mol Biol 36(1): 1-7.
42. Hardin DS. 2004; GH improves growth and clinical status in children with cystic fibrosis - a review of published studies. Eur J Endocrinol Eur Fed Endocr Soc 151(1): 81-85.
43. Hegab AE, Ha VL, Gilbert JL, et al. 2011; Novel stem/progenitor cell population from murine tracheal submucosal gland ducts with multipotent regenerative potential. Stem Cells 29(8): 1283-1293.
44. Herzog EL, Van Arnam J, Hu B, et al. 2006; Threshold of lung injury required for the appearance of marrow-derived lung epithelia. Stem Cells 24(8): 1986-1992.
45. Hilliard TN, Regamey N, Shute JK, et al. 2007; Airway remodelling in children with cystic fibrosis. Thorax 62(12): 1074-1080.
46. Hoiby N 1988; Haemophilus influenzae, Staphylococcus aureus, Pseudomonas cepacia, and Pseudomonas aeruginosa in patients with cystic fibrosis. Chest 94(2): 97-103.
47. Ilancheran S, Michalska A, Peh G, et al. 2007; Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod 77(3): 577-588.
48. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. 2003; Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102(4): 1548-1549.
49. Itskovitz-Eldor J, Schuldiner M, Karsenti D, et al. 2000; Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 6(2): 88-95.
50. Jensen T, Roszell B, Zang F, et al. 2012; A rapid lung decellularization protocol supports embryonic stem cell differentiation in vitro and following implantation. Tissue Eng Part C Methods 18(8): 632-646.
51. Johnson LG, Olsen JC, Sarkadi B, et al. 1992; Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat Genet 2(1): 21-25.
52. Kaji K, Norrby K, Paca A, et al. 2009; Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458(7239): 771-775.
53. Kajstura J, Rota M, Hall SR, et al. 2011; Evidence for human lung stem cells. N Engl J Med 364(19): 1795-1806.
54. Kammouni W, Moreau B, Becq F, et al. 1999; A cystic fibrosis tracheal gland cell line, CF-KM4. Correction by adenovirus-mediated CFTR gene transfer. Am J Resp Cell Mol Biol 20(4): 684-691.
55. Kaufman DS, Hanson ET, Lewis RL, et al. 2001; Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 98(19): 10716-10721.
56. Kehat I, Kenyagin-Karsenti D, Snir M, et al. 2001; Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108(3): 407-414.
57. Kerem B, Rommens JM, Buchanan JA, et al. 1989; Identification of the cystic fibrosis gene: genetic analysis. Science 245(4922): 1073-1080.
58. Khan TZ, Wagener JS, Bost T, et al. 1995; Early pulmonary inflammation in infants with cystic fibrosis. Am J Resp Crit Care Med 151(4): 1075-1082.
59. Kim CF, Jackson EL, Woolfenden AE, et al. 2005; Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121(6): 823-835.
60. Kinder SJ, Loebel DA, Tam PP. 2001; Allocation and early differentiation of cardiovascular progenitors in the mouse embryo. Trends Cardiovasc Med 11(5): 177-184.
61. Kolambkar YM, Peister A, Soker S, et al. 2007; Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol 38(5): 405-413.
62. Krasnodembskaya A, Song Y, Fang X, et al. 2010; Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 28(12): 2229-2238.
63. Lee JW, Fang X, Krasnodembskaya A, et al. 2011; Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells 29(6): 913-919.
64. Lee MW, Choi J, Yang MS, et al. 2004; Mesenchymal stem cells from cryopreserved human umbilical cord blood. Biochem Biophys Res Commun 320(1): 273-278.
65. Lek N, Acerini CL. 2010; Cystic fibrosis related diabetes mellitus - diagnostic and management challenges. Curr Diabet Rev 6(1): 9-16.
66. Levenberg S, Golub JS, Amit M, et al. 2002; Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 99(7): 4391-4396.
67. Li H, Niederkorn JY, Neelam S, et al. 2005; Immunosuppressive factors secreted by human amniotic epithelial cells. Invest Ophthalmol Vis Sci 46(3): 900-907.
68. Liu X, Luo M, Guo C, et al. 2009; Analysis of adeno-associated virus progenitor cell transduction in mouse lung. Mol Ther 17(2): 285-293.
69. Loi R, Beckett T, Goncz KK, et al. 2006; Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells. Am J Resp Crit Care Med 173(2): 171-179.
70. Longmire TA, Ikonomou L, Hawkins F, et al. 2012; Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells. Cell Stem Cell 10(4): 398-411.
71. Martin GR. 1981; Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78(12): 7634-7638.
72. Mateizel I, De Temmerman N, Ullmann U, et al. 2006; Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod 21(2): 503-511.
73. Mishra S, Wang X, Smiley N, et al. 2011; Genetic modification of airway progenitors after lentiviral gene delivery to the amniotic fluid of murine fetuses. Am J Resp Cell Mol Biol 44(4): 562-570.
74. Mou H, Zhao R, Sherwood R, et al. 2012; Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs. Cell Stem Cell 10(4): 385-397.
75. Mountford JC. 2008; Human embryonic stem cells: origins, characteristics and potential for regenerative therapy. Transfus Med 18(1): 1-12.
76. Muhlebach MS, Noah TL. 2002; Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis. Am J Resp Crit Care Med 165(7): 911-915.
77. Murphy S, Lim R, Dickinson H, et al. 2011a; Human amnion epithelial cells prevent bleomycin-induced lung injury and preserve lung function. Cell Transpl 20(6): 909-923.
78. Murphy S, Rosli S, Acharya R, et al. 2010; Amnion epithelial cell isolation and characterization for clinical use. Curr Protoc Stem Cell Biol 13:1E.6.1-1E.6.25.
79. Murphy S, Wallace E, Jenkin G. 2011b; Placental-derived stem cells: potential clinical applications. In Stem Cells and Regenerative Medicine, Appasani K, Appasani RK (eds). Humana: New York; 243-263.
80. Murphy SV, Lim R, Heraud P, et al. 2012a; Human amnion epithelial cells induced to express functional cystic fibrosis transmembrane conductance regulator. PLoS One 7(9): e46533.
81. Murphy SV, Shiyun SC, Tan JL, et al. 2012b; Human amnion epithelial cells do not abrogate pulmonary fibrosis in mice with impaired macrophage function. Cell Transpl 21(7): 1477-1492.
82. Nakahara H, Goldberg VM, Caplan AI. 1991; Culture-expanded human periosteal-derived cells exhibit osteochondral potential in vivo. J Orthop Res 9(4): 465-476.
83. Nichols DP, Konstan MW, Chmiel JF. 2008; Anti-inflammatory therapies for cystic fibrosis-related lung disease. Clin Rev Allergy Immunol 35(3): 135-153.
84. Olivier AK, Yi Y, Sun X, et al. 2012; Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets. J Clin Invest 122(10): 3755-3768.
85. Ortiz LA, Gambelli F, McBride C, et al. 2003; Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 100(14): 8407-8411.
86. Ostedgaard LS, Rogers CS, Dong Q, et al. 2007; Processing and function of CFTR-DeltaF508 are species-dependent. Proc Natl Acad Sci USA 104(39): 15370-15375.
87. Ott HC, Clippinger B, Conrad C, et al. 2010; Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 16(8): 927-933.
88. Painter RG, Valentine VG, Lanson NA Jr, et al. 2006; CFTR expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. Biochemistry 45(34): 10260-10269.
89. Paracchini V, Carbone A, Colombo F, et al. 2012; Amniotic mesenchymal stem cells: a new source for hepatocyte-like cells and induction of CFTR expression by coculture with cystic fibrosis airway epithelial cells. J Biomed Biotechnol 2012(1): 575471.
90. Petersen TH, Calle EA, Zhao L, et al. 2010; Tissue-engineered lungs for in vivo implantation. Science 329(5991): 538-541.
91. Pickering SJ, Minger SL, Patel M, et al. 2005; Generation of a human embryonic stem cell line encoding the cystic fibrosis mutation δF508, using preimplantation genetic diagnosis. Reprod Biomed Online 10(3): 390-397.
92. Quinton PM. 2007; Cystic fibrosis: lessons from the sweat gland. Physiology 22(1): 212-225.
93. Regamey N, Jeffery PK, Alton EW, et al. 2011; Airway remodelling and its relationship to inflammation in cystic fibrosis. Thorax 66(7): 624-629.
94. Ren G, Zhang L, Zhao X, et al. 2008; Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2(2): 141-150.
95. Reubinoff BE, Itsykson P, Turetsky T, et al. 2001; Neural progenitors from human embryonic stem cells. Nat Biotechnol 19(12): 1134-1140.
96. Riordan JR, Rommens JM, Kerem B, et al. 1989; Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245(4922): 1066-1073.
97. Rock JR, Onaitis MW, Rawlins EL, et al. 2009; Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc Natl Acad Sci USA 106(31): 12771-12775
98. Rogers CS, Stoltz DA, Meyerholz DK, et al. 2008; Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321(5897): 1837-1841.
99. Rommens JM, Iannuzzi MC, Kerem B, et al. 1989; Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245(4922): 1059-1065.
100. Rosenfeld M, Gibson RL, McNamara S, et al. 2001; Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 32(5): 356-366.
101. Samadikuchaksaraei A, Cohen S, Isaac K, et al. 2006; Derivation of distal airway epithelium from human embryonic stem cells. Tissue Eng 12(4): 867-875.
102. Sangiuolo F, Scaldaferri ML, Filareto A, et al. 2008; Cftr gene targeting in mouse embryonic stem cells mediated by small fragment homologous replacement (SFHR). Front Biosci 13(1): 2989-2999.
103. Schuldiner M, Eiges R, Eden A, et al. 2001; Induced neuronal differentiation of human embryonic stem cells. Brain Res 913(2): 201-205.
104. Serikov V, Hounshell C, Larkin S, et al. 2009; Human term placenta as a source of hematopoietic cells. Exp Biol Med 234(7): 813-823.
105. Somers A, Jean JC, Sommer CA, et al. 2010; Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells 28(10): 1728-1740.
106. Stadtfeld M, Nagaya M, Utikal J, et al. 2008; Induced pluripotent stem cells generated without viral integration. Science 322(5903): 945-949.
107. Stoltz DA, Meyerholz DK, Pezzulo AA, et al. 2010; Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Translat Med 2(29): 29-31.
108. Sueblinvong V, Loi R, Eisenhauer PL, et al. 2008; Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells. Am J Resp Crit Care Med 177(7): 701-711.
109. Sun X, Sui H, Fisher JT, et al. 2010; Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J Clin Invest 120(9): 3149-3160.
110. Sun X, Yan Z, Yi Y, et al. 2008; Adeno-associated virus-targeted disruption of the CFTR gene in cloned ferrets. J Clin Invest 118(4): 1578-1583.
111. Takahashi K, Tanabe K, Ohnuki M, et al. 2007; Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5): 861-872.
112. Taupin P 2006; Therapeutic potential of adult neural stem cells. Recent Patents CNS Drug Discov 1(3): 299-303.
113. Thomson JA, Itskovitz-Eldor J, Shapiro S, et al. 1998; Embryonic stem cell lines derived from human blastocysts. Science 282(5391): 1145-1147.
114. Tolar J, Le Blanc K, Keating A, et al. 2010; Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells 28(8): 1446-1455.
115. Troyer DL, Weiss ML. 2008; Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26(3): 591-599.
116. Uccelli A, Moretta L, Pistoia V. 2008; Mesenchymal stem cells in health and disease. Nature Rev Immunol 8(9): 726-736.
117. van der Flier LG, Clevers H. 2009; Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 71(1): 241-260.
118. Wallis JM, Borg ZD, Daly AB, et al. 2012; Comparative assessment of detergent-based protocols for mouse lung de-cellularization and re-cellularization. Tissue Eng Part C Methods 18(6): 420-432.
119. Wang D, Haviland DL, Burns AR, et al. 2007; A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 104(11): 4449-4454.
120. Wang G, Bunnell BA, Painter RG, et al. 2005; Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proc Natl Acad Sci USA 102(1): 186-191.
121. Weiner LP. 2008; Definitions and criteria for stem cells. Methods Mol Biol 438(1): 3-8.
122. Welsh MJ, Rogers CS, Stoltz DA, et al. 2009; Development of a porcine model of cystic fibrosis. Trans Am Clin Climatol Assoc 120: 149-162.
123. Wong AP, Bear CE, Chin S, et al. 2012; Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein. Nat Biotechnol 30(9): 876-882.
124. Young HE, Steele TA, Bray RA, et al. 2001; Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 264(1): 51-62.
125. Yu J, Vodyanik MA, Smuga-Otto K, et al. 2007; Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858): 1917-1920.
126. Zheng YB, Gao ZL, Xie C, et al. 2008; Characterization and hepatogenic differentiation of mesenchymal stem cells from human amniotic fluid and human bone marrow: a comparative study. Cell Biol Int 32(11): 1439-1448.
127. Zhou H, Wu S, Joo JY, et al. 2009; Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4(5): 381-384.
128. Zhou Z, Duerr J, Johannesson B, et al. 2011; The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease. J Cystic Fibrosis 10(Suppl 2): S172-182.
129. Zuk PA, Zhu M, Mizuno H, et al. 2001; Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7(2): 211-228.
130. Zvaifler NJ, Marinova-Mutafchieva L, Adams G, et al. 2000; Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2(6): 477-488.